Patel R, Fukui J, Klein P, Moshier E, et al. Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer. Breast Cancer Res Treat 2025 Aug 16. doi: 10.1007/s10549-025-07802.
PMID: 40817986